| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 06/29/2000 | WO2000037163A1 Integrated portable biological detection system |
| 06/29/2000 | WO2000015809A3 Uracil permease from arabidopsis as herbicidal target gene |
| 06/29/2000 | WO2000012129A3 Salmonella typhi vaccine compositions |
| 06/29/2000 | WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions |
| 06/29/2000 | WO2000006737A3 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 06/29/2000 | WO2000006717A3 Improved transformation efficiency in phage display through modification of a coat protein |
| 06/29/2000 | WO2000006605A3 Heterominibodies |
| 06/29/2000 | WO1999066028A3 Genes for the biosynthesis of epothilones |
| 06/29/2000 | DE19857302A1 Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren und deren Ester A process for the enantioselective reduction of 3,5-Dioxocarbonsäuren and esters thereof |
| 06/29/2000 | CA2776920A1 Method for producing ascorbic acid intermediates |
| 06/29/2000 | CA2357004A1 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
| 06/29/2000 | CA2356244A1 Somatic cells with ablated prp gene and methods of use |
| 06/29/2000 | CA2355604A1 Novel variant egiii-like cellulase compositions |
| 06/29/2000 | CA2354843A1 Outer surface proteins, their genes, and their use |
| 06/29/2000 | CA2353799A1 Methods and compositions for inhibiting neoplastic cell growth |
| 06/29/2000 | CA2353461A1 Integrated portable biological detection system |
| 06/29/2000 | CA2321450A1 Process for producing (r)-2-hydroxy-1-phenoxypropane derivative |
| 06/28/2000 | EP1013771A1 Non-nuclear chromosomal transformation |
| 06/28/2000 | EP1013765A1 Gene and method for producing L-amino acids |
| 06/28/2000 | EP1013764A1 Immunomodulators |
| 06/28/2000 | EP1013761A2 Humanized chimeric antibody directed against ganglioside GD3 |
| 06/28/2000 | EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same |
| 06/28/2000 | EP1013665A1 Novel polypeptide having water channel activity and dna sequence |
| 06/28/2000 | EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/28/2000 | EP1013285A2 Urokinase-type plasminogen activator receptor |
| 06/28/2000 | EP1012323A1 A method for the production of dicarboxylic acids |
| 06/28/2000 | EP1012315A1 Recombinant vectors |
| 06/28/2000 | EP1012310A1 Fusion proteins comprising coiled-coil structures |
| 06/28/2000 | EP1012298A1 Yeast strains for the production of lactic acid |
| 06/28/2000 | EP1012295A1 Alphavirus rna replicon systems |
| 06/28/2000 | EP1012294A2 Microbial genes for secreted beta-glucuronidases, gene products and uses thereof |
| 06/28/2000 | EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 06/28/2000 | EP1012289A1 A recombinant expression vector of human parathyroid hormone using phosphoribulokinase as a fusion partner |
| 06/28/2000 | EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them |
| 06/28/2000 | EP1012261A1 Secreted proteins and polynucleotides encoding them |
| 06/28/2000 | EP1012254A1 Method for reducting bioavailability of lead by a lead-sequestering soil bacterium |
| 06/28/2000 | EP1012243A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
| 06/28/2000 | EP1012232A1 Genetically modified tumor-targeted bacteria with reduced virulence |
| 06/28/2000 | EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/28/2000 | EP1011721A1 Vaginal lactobacillus medicant |
| 06/28/2000 | EP1011717A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
| 06/28/2000 | EP0707655B1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy |
| 06/28/2000 | EP0639224B1 Lectin domain variants of selectin |
| 06/28/2000 | EP0557418B1 A beta-type transforming growth factor |
| 06/28/2000 | CN1257930A Method for fermentation production of L-amino acid |
| 06/28/2000 | CN1257872A Leptospiral vaccine antigen for preventing leptospirosis |
| 06/28/2000 | CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition |
| 06/27/2000 | US6080915 Constructs encoding degradation enzymes for aromatic compounds and transgenic plants containing same |
| 06/27/2000 | US6080718 Useful in the identification and isolation of components involved in transmembrane receptor-mediated signaling |
| 06/27/2000 | US6080717 Treatment of individual having a need to inhibit a polypeptide, comprising administering a bactericidal antagonist of the polypeptide |
| 06/27/2000 | US6080582 Cell tests for Alzheimer's disease |
| 06/27/2000 | US6080578 Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia |
| 06/27/2000 | US6080575 Isolated nucleic acid construct for expressing a biologically active substance which is activated by an enzyme released from mammalian cells; for target cell-specific therapy for tumors and inflammation |
| 06/27/2000 | US6080572 Sulphate-reducing bacterial strains and their use in the decontamination of water contaminated with sulphuric acid, metals and radioactive substances |
| 06/27/2000 | US6080562 Producing microorganism that synthesizes 3-hydroxybutyrate-3-hydroxyvalerate copolymer when cultivated on substrate containing a component by selection, induction and isolation |
| 06/27/2000 | US6080559 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus |
| 06/27/2000 | US6080553 Creatine amidinohydrolase, production thereof and use thereof |
| 06/27/2000 | US6080545 Oligonucleotides for the detection of salmonella |
| 06/27/2000 | US6080540 Expressing mammalian gene in a recombinant microorganism causing modified phenotype associated with mutation, incubating with chemical, determining if altered phenotype is reversed indicating that agent suppresses the mammalian gene |
| 06/27/2000 | US6080398 Chemokines modified by truncation of from 2 to 8 amino acids from the amino terminus of the corresponding mature chemokine selected from kc, gro-beta, gro-gamma, and gro-alpha; lower dose needed, less toxicity |
| 06/27/2000 | CA2198603C Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cells |
| 06/27/2000 | CA2171327C Synthesis of adipic acid from biomass-derived carbon sources |
| 06/27/2000 | CA2134083C Prophylactic and therapeutic agents for autoimmune diseases |
| 06/27/2000 | CA2089553C Multidomain hematopoiesis stimulators |
| 06/27/2000 | CA2063195C Inositol-excreting yeast |
| 06/27/2000 | CA1341037C .alpha.-amidation enzyme |
| 06/23/2000 | CA2291454A1 Novel gene and method for producing l-amino acids |
| 06/22/2000 | WO2000036135A2 Screening methods based on the use of protein kinases |
| 06/22/2000 | WO2000036134A1 Method for the enantioselective reduction of 3,5-dioxocarboxylic acids, their salts and their esters |
| 06/22/2000 | WO2000036133A1 Process for producing polypeptide in cell-free protein synthesis system |
| 06/22/2000 | WO2000036102A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/22/2000 | WO2000036092A2 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 06/22/2000 | WO2000036090A2 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells |
| 06/22/2000 | WO2000036086A1 Novel microorganisms and process for producing amide compounds |
| 06/22/2000 | WO2000035483A1 Methods and products for regulating lectin complement pathway associated complement activation |
| 06/22/2000 | WO2000035481A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 06/22/2000 | WO2000024920A3 METHOD OF PRODUCING η-DECALACTONE |
| 06/22/2000 | WO2000010013A3 Composition and methods for exposing antigenic epitopes on cultered microorganism |
| 06/22/2000 | WO2000009695A3 Drug targets in candida albicans |
| 06/22/2000 | WO2000009681A3 CONSTRUCTION OF NORMALIZED cDNA LIBRARIES FROM EUCARYOTIC CELLS |
| 06/22/2000 | WO2000006736A3 Nucleic acids and proteins from group b streptococcus |
| 06/22/2000 | CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
| 06/22/2000 | CA2355362A1 Screening methods based on the use of protein kinases |
| 06/22/2000 | CA2355270A1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 06/22/2000 | CA2354539A1 A method for the high level expression of active lymphotoxin-.beta. receptor immunoglobulin chimeric proteins and their purification |
| 06/22/2000 | CA2354534A1 Process for producing polypeptide in cell-free protein synthesis system |
| 06/22/2000 | CA2353561A1 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells |
| 06/22/2000 | CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
| 06/22/2000 | CA2290219A1 Leptospira vaccine antigens for the prevention of leptospirosis |
| 06/21/2000 | EP1010760A1 Lumazine synthase and riboflavin synthase |
| 06/21/2000 | EP1010757A2 Insertion sequence from Methylococcus capsulatus |
| 06/21/2000 | EP1010753A1 $i(BIFIDOBACTERIUM BREVE) AND FERMENTED SOY-MILK PREPARED WITH THE SAME |
| 06/21/2000 | EP1009836A1 Expression vector for improved production of polypeptides in yeast |
| 06/21/2000 | EP1009833A1 Prenylcysteine carboxyl methyl-transferase, dna enconding same, and a method of screening for inhibitors thereof |
| 06/21/2000 | EP1009825A1 Zcytor7 cytokine receptor |
| 06/21/2000 | EP1009817A1 Rtd receptor |
| 06/21/2000 | EP1009815A1 Protease variants and compositions |
| 06/21/2000 | EP1009814A1 Human receptor tyrosine kinase, kdr |
| 06/21/2000 | EP1009812A1 Transgenic plants with tocopherol methyltransferase |
| 06/21/2000 | EP1009810A2 MUTANT $i(THERMOMONOSPORA SPP.) CELLULASE |